Purchase Order HU000120PT088
Award Date 9/18/20
Potential Completion Date 3/21/21
Potential Value $1.9M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order awarded by the Uniformed Services University of the Health Sciences, a Defense agency, to Illumina, Inc. for the provision of a NovaSeq X Plus Sequencing System. The $1,083,750.00 contract does not have a set-aside designation. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis, and has a history of providing sequencing systems, reagents, and related services to support research and...
- This firm fixed-price purchase order contract was awarded by the Medical Command (MEDCOM) of the U.S. Department of Defense to Illumina, Inc., a manufacturer of genomic sequencing systems and analytical tools. The $282,150.00 contract provides for the delivery of a MiSeq diagnostic sequencing system to support research and analysis at the U.S. Army's Fort Detrick facility in Maryland. Illumina has previously provided sequencing platforms and related services to federal agencies including the...
- This firm-fixed-price purchase order was awarded by the U.S. Department of the Navy's Bureau of Medicine and Surgery to Illumina, Inc., a for-profit manufacturer of biotechnology and genomic analysis products, for the delivery of one NovaSeq 6000 sequencing system. The $945,107.50 contract will support COVID-19 research at the Naval Medical Research Center in Fort Detrick, Maryland. The contract includes installation and training services. This requirement was a brand name-only solicitation with...
- The U.S. Navy's Bureau of Medicine and Surgery awarded a $98,929.70 firm fixed price purchase order to Illumina, Inc. for one MiSeq i100 Plus System with associated installation and operational qualification services. The contract, with an ultimate completion date of October 14, 2025, supports the Naval Health Research Center in San Diego, California, a military medical research facility. This procurement was conducted as a sole-source award under the authority of 10 U.S.C. 3204(a)(1), with no...
- This is a firm fixed price delivery order awarded by the Medical Command (MEDCOM) of the U.S. Department of Defense to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $110,534.40 contract is for the provision of various NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, accompanying reagents and consumables, sample prep kits, sequencing chips, support plans, maintenance services, and bioinformatics products. This delivery order is issued under...
- This is a $99,835.14 firm fixed price purchase order awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of Defense, to Illumina, Inc. The contract is for the provision of Illumina RNA sequencing products and reagents, including NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, sample preparation kits, sequencing chips, and related consumables and support services. These items will support genomic sequencing and bioinformatics analysis for research and...
- The Department of the Air Force Headquarters District Washington awarded Illumina, Inc. a $327,500 firm fixed price purchase order for NEXSEQ 500 sequencing systems and associated supplies. As the sole manufacturer of the proprietary sequencing platforms required, Illumina will deliver the goods and services to support genomic analysis needs at a location in San Diego, California. No set-aside provision was applied to this acquisition of Next Generation Sequencing technology from the...
- This firm fixed price purchase order was awarded by the Defense Health Agency to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The $630,846 contract is for the provision of a NEXTSEQ 550DX SEQUENCING SYSTEM, with a completion date of November 30, 2018. Illumina has a history of providing a range of sequencing equipment and supplies to federal agencies like the NIH, CDC, USDA, and VA for research and diagnostic purposes. Additionally, Illumina holds an...
- This is a firm-fixed-price purchase order awarded by the Naval Medical Research Command to Illumina, Inc., a for-profit manufacturer of genomic sequencing technologies. The requirement is for a MiSeq i100 Plus System, a specialized DNA/RNA sequencing instrument. The $90,997.20 contract has an ultimate completion date of July 30, 2025. Illumina is a prime contractor providing a range of genomic sequencing platforms, reagents, consumables, and maintenance services to multiple federal civilian...
- This is a firm fixed price purchase order awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Illumina, Inc., a manufacturer of genomic sequencing instrumentation and reagents. The $153,192.00 contract is for the provision of a MiSeq Silver sequencing system and associated products to support the agency's nucleic acid sequencing needs, specifically to characterize biological threats at the Naval Medical Research Center's Biological Defense Research...